Find the latest firm updates, including news articles, media coverage, press releases, blog posts, and legal publications. Stay up to date on our ongoing cases, attorney achievements, and important developments shaping personal injury law and related fields.
FOR IMMEDIATE RELEASE Meyers & Flowers Secures Spot in Top 10 Medical Malpractice Verdicts of 2023 with $43.5 Million Jury Award CHICAGO – Meyers & Flowers is proud to announce that its $43.5 million jury…
Meyers & Flowers welcomes Betsy Holder as Of Counsel to expand legal services in Champaign, Illinois. Champaign, IL – Meyers & Flowers, a leading law firm known for its commitment to justice and excellence in…
Chicago, IL, November 2024 – Meyers & Flowers, LLC is proud to announce its inclusion in the 2025 Edition of Best Law Firms®, a prestigious ranking by Best Lawyers® that recognizes firms for their professional…
Ron Simon & Associates and Meyers & Flowers have filed the first lawsuits in response to a recent E. coli outbreak linked to McDonald’s restaurants. The lawsuits were filed on behalf of two residents—one from Colorado and…
The Environmental Protection Agency (EPA) has recently taken significant steps to protect public health by issuing an emergency directive suspending the use of Dacthal, a widely used pesticide linked to serious health risks. This suspension comes…
Depo-Provera, a popular contraceptive injection, has been at the center of recent legal action due to its potential link to serious health issues, particularly meningiomas—tumors that form in the membranes surrounding the brain and spinal…
A group of 47 members of Congress, led by Rep. Greg Casar, has called on the Environmental Protection Agency (EPA) to ban the herbicide paraquat, which has been linked to Parkinson’s disease and cancer. This…
Fisher-Price has issued a recall of more than 2 million “Snuga Swings” due to a suffocation risk, with five infant deaths linked to the product between 2012 and 2022. The swings were reportedly used improperly…
Acadia Healthcare, one of the largest psychiatric hospital chains in the U.S., has been mired in controversy for years due to allegations of unethical practices and fraudulent detainment of patients. The company has faced numerous…
Pfizer has issued a global recall of Oxbryta, a drug approved for the treatment of sickle cell disease (SCD). Oxbryta, which aimed to improve oxygen transport in red blood cells, offered hope to many individuals…
